MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathwayPrabhudutta Mamidi(Institute of Life Sciences), Soma Chattopadhyay(Argonne National Laboratory)bioRxiv (Cold Spring Harbor Laboratory)May 26, 202110.1101/2021.05.26.445768Cited by 1SaveCiteExport RISWatch citationsRelated PapersMicroscopic description of the evolution of the local structure and an evaluation of the chemical pressure concept in a solid solution|Physical Review B|2014|32Chikungunya virus perturbs the Wnt/β-catenin signaling pathway for efficient viral infection|Journal of Virology|2023|17Referee report. For: Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts [version 1; referees: 1 approved, 1 approved with reservations]|Faculty of 1000 Research Ltd|2018|0